Online inquiry

IVTScrip™ mRNA-Human ADRB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8968MR)

This product GTTS-WK8968MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADRB2 protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_000024.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 154
UniProt ID P07550
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADRB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8968MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19518MR IVTScrip™ mRNA-Human AGTRAP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AGTRAP
GTTS-WK10399MR IVTScrip™ mRNA-Human ADAMTS14, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAMTS14
GTTS-WK9491MR IVTScrip™ mRNA-Human ADAM17, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAM17
GTTS-WK13517MR IVTScrip™ mRNA-Human AARD, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AARD
GTTS-WK14288MR IVTScrip™ mRNA-Human ADAM10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM10
GTTS-WK25837MR IVTScrip™ mRNA-Human APOLD1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APOLD1
GTTS-WK22979MR IVTScrip™ mRNA-Human ARRDC2, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARRDC2
GTTS-WK26000MR IVTScrip™ mRNA-Human ASB8, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ASB8
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →